Sanochemia Pharmazeutika AG (SAC) - Financial and Strategic SWOT Analysis Review

Report code: GDPH81763FSA

Publisher: GlobalData

Formats: PDF

Published: November 22, 2016

Number of pages: 37

Sanochemia Pharmazeutika AG (Sanochemia) is a specialty pharmaceutical company that develops and manufactures of innovative drugs and diagnostics in selected indication areas such as neurodegeneration, pain and cancer, as well as diagnostic products based on contrast media. The company’s product portfolio includes radiological products including an array of x-ray imaging agents and the MRT imaging agent; and veterinary pharmaceuticals. It also offers synthesis of active pharmaceutical substances (APIs), drug formulation and pharmaceutical production and contract research. Apart from Austria, Sanochemia offers its products in Remaining Europe, Asia, MENA (Middle East and North Africa), Commonwealth of Independent States (CIS) countries and rest of the world. The company has sales offices in Switzerland, Germany, the UK and the US. Sanochemia is headquartered in Vienna, Austria.

Sanochemia Pharmazeutika AG (SAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Scope

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Reason To Buy

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Section 1 - About the Company 5

Sanochemia Pharmazeutika AG - Key Facts 5

Sanochemia Pharmazeutika AG - Key Employees 6

Sanochemia Pharmazeutika AG - Key Employee Biographies 7

Sanochemia Pharmazeutika AG - Major Products and Services 8

Sanochemia Pharmazeutika AG - Pharmaceutical Pipeline Products Data 9

Sanochemia Pharmazeutika AG, Pipeline Products by Therapy Area 9

Sanochemia Pharmazeutika AG, Pipeline Products by Development Phase 10

Sanochemia Pharmazeutika AG - History 11

Sanochemia Pharmazeutika AG - Company Statement 14

Sanochemia Pharmazeutika AG - Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2 – Company Analysis 17

Sanochemia Pharmazeutika AG - Business Description 17

Sanochemia Pharmazeutika AG - Corporate Strategy 18

Sanochemia Pharmazeutika AG - SWOT Analysis 19

SWOT Analysis - Overview 19

Sanochemia Pharmazeutika AG - Strengths 19

Sanochemia Pharmazeutika AG - Weaknesses 20

Sanochemia Pharmazeutika AG - Opportunities 21

Sanochemia Pharmazeutika AG - Threats 22

Sanochemia Pharmazeutika AG - Key Competitors 23

Section 3 – Company Financial Ratios 24

Financial Ratios - Capital Market Ratios 24

Financial Ratios - Annual Ratios 25

Performance Chart 27

Financial Performance 27

Financial Ratios - Interim Ratios 28

Financial Ratios - Ratio Charts 29

Section 4 – Company’s Lifesciences Financial Deals and Alliances 30

Sanochemia Pharmazeutika AG, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 30

Sanochemia Pharmazeutika AG, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 31

Sanochemia Pharmazeutika AG, Recent Deals Summary 32

Section 5 – Appendix 33

Methodology 33

Ratio Definitions 33

About GlobalData 37

Contact Us 37

Disclaimer 37

List of Tables

List of Tables

Sanochemia Pharmazeutika AG, Key Facts 5

Sanochemia Pharmazeutika AG, Key Employees 6

Sanochemia Pharmazeutika AG, Key Employee Biographies 7

Sanochemia Pharmazeutika AG, Major Products and Services 8

Sanochemia Pharmazeutika AG, Number of Pipeline Products by Therapy Area 9

Sanochemia Pharmazeutika AG, Number of Pipeline Products by Development Stage 10

Sanochemia Pharmazeutika AG, Pipeline Products By Therapy Area and Development Phase 10

Sanochemia Pharmazeutika AG, History 11

Sanochemia Pharmazeutika AG, Other Locations 15

Sanochemia Pharmazeutika AG, Subsidiaries 15

Sanochemia Pharmazeutika AG, Key Competitors 23

Sanochemia Pharmazeutika AG, Ratios based on current share price 24

Sanochemia Pharmazeutika AG, Annual Ratios 25

Sanochemia Pharmazeutika AG (Cont...1), Annual Ratios 26

Sanochemia Pharmazeutika AG, Interim Ratios 28

Sanochemia Pharmazeutika AG, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 30

Sanochemia Pharmazeutika AG, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 31

Sanochemia Pharmazeutika AG, Recent Deals Summary 32

Currency Codes 33

Capital Market Ratios 33

Equity Ratios 34

Profitability Ratios 34

Cost Ratios 35

Liquidity Ratios 35

Leverage Ratios 35

Efficiency Ratios 36

List of Figures

List of Figures

Sanochemia Pharmazeutika AG, Pipeline Products by Therapy Area 9

Sanochemia Pharmazeutika AG, Pipeline Products by Development Phase 10

Sanochemia Pharmazeutika AG, Performance Chart (2011 - 2015) 27

Sanochemia Pharmazeutika AG, Ratio Charts 29

Sanochemia Pharmazeutika AG, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 30

Sanochemia Pharmazeutika AG, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 31

Save time and money with a subscription

Require regular access to company intelligence? Why not consider a cost-effective subscription platform and gain access to 250,000+ reports?

To find out more, click here or call +44 161 359 5819.

Single User License
Electronic PDF copy delivered via email.

Report can be used by individual purchaser only.

$125

Site License
Electronic PDF copy delivered via email.

Report can be shared by unlimited users within one corporate location,
e.g. a regional office.

$250

Global License
Electronic PDF copy delivered via email.

Report can be shared globally by unlimited users within the purchasing corporation
e.g. all employees of a single company.

$375

TOP